![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
36 episodios
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
Intention to Treat NEJM Group
-
- Salud y forma física
“Intention to Treat,” hosted by health care journalist Rachel Gotbaum, draws on the world-class expertise of the New England Journal of Medicine to present breaking news and incisive analysis of critical and timely issues in medicine and health care. Through interviews with NEJM editors, specialized experts, physicians, and affected patients, each episode explores a story-behind-the-story, giving listeners needed context and a deeper understanding of complex research, cutting-edge medical interventions, and urgent health policy debates that affect patients and the clinicians who care for them. Practicing clinicians, biomedical researchers, medical trainees, patients, and anyone with an interest in health will find unique insights in “Intention to Treat.”
-
Race-Based Diagnosis, Part 2
A key measure of kidney function and a risk calculator for vaginal birth after cesarean delivery are among the many tools that have long contributed to health and health care inequities for Black patients.
A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2405797. -
Race-Based Diagnosis, Part 1
Claims that Black people had lower lung capacity than White people led to race-adjusted spirometry and poorer care for Black patients with lung disease. New equations are starting to change that.
A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2405796. -
Are We Prepared for Bird Flu?
A new strain of H5N1 influenza is spreading in dairy cows in the United States. Will it cause an epidemic in humans? And what does our public health system need to do in order to be ready if it does?
A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2405795. -
Treating Obesity in Kids
In the face of a growing childhood obesity epidemic, some parents and clinicians are turning to new tools such as GLP-1 receptor agonists. This episode explores the implications of that trend.
A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2400703. -
New Hope for a Common and Deadly Heart Condition
This episode considers a new treatment for hypertrophic cardiomyopathy, the world’s most common inherited heart condition, which most affected people don’t even realize they have.
A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2400702. -
CAR T-Cells and Safety Signals
This episode examines CAR T-cell therapy’s early successes, broader promise, and emerging risks, as the FDA considers reports of occasional secondary cancers.
A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2400701.